Capital Fund Management S.A. Gilead Sciences, Inc. Call Options Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $26.1 Million - $32.9 Million	-391,800 Reduced 31.91%	836,200 $70.1 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $69.6 Million - $80.3 Million	1,102,300 Added 876.93%	1,228,000 $84.3 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $55.6 Million - $67.8 Million	-776,900 Reduced 86.07%	125,700 $9.21 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $36.3 Million - $41.2 Million	-495,900 Reduced 35.46%	902,600 $73.1 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $12.5 Million - $13.6 Million	-169,200 Reduced 10.79%	1,398,500 $105 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $53.4 Million - $60.9 Million	701,900 Added 81.07%	1,567,700 $121 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $53.6 Million - $61.1 Million	693,300 Added 401.91%	865,800 $71.8 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $6.18 Million - $8.87 Million	99,100 Added 135.01%	172,500 $14.8 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $11.7 Million - $13.4 Million	-196,300 Reduced 72.78%	73,400 $4.53 Billion
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $1.88 Million - $2.11 Million	-32,500 Reduced 10.75%	269,700 $16.7 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $12.8 Million - $16.1 Million	221,700 Added 275.4%	302,200 $18 Million
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $21.8 Million - $24.8 Million	-336,100 Reduced 80.68%	80,500 $5.85 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $27.9 Million - $30.1 Million	-412,400 Reduced 49.75%	416,600 $29.1 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $10.3 Million - $11.3 Million	-162,800 Reduced 16.41%	829,000 $57.1 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $13.5 Million - $15.4 Million	224,900 Added 29.33%	991,800 $64.1 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $39.5 Million - $45 Million	697,400 Added 1003.45%	766,900 $44.7 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $161,460 - $203,008	2,600 Added 3.89%	69,500 $4.39 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $671,994 - $876,900	-11,100 Reduced 14.23%	66,900 $4.19 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $1.68 Million - $1.86 Million	23,600 Added 43.38%	78,000 $6.02 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $629,336 - $734,096	-9,700 Reduced 15.13%	54,400 $3.85 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $1.25 Million - $1.52 Million	17,100 Added 36.38%	64,100 $4.83 Million
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $14.8 Million - $17.4 Million	-208,500 Reduced 81.6%	47,000 $3.37 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $18.4 Million - $21.8 Million	255,500	255,500 $20.7 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.7 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.78 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.48 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.33 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account